ArticleFrontiers in medicine2025
Nomogram-based model to predict prognosis in anisometropic amblyopia.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to identify predictive factors and develop an effective nomogram to estimate the prognosis of anisometropic amblyopia. Methods: We retrospectively analyzed 2,897 patients aged 3-18 years diagnosed with anisometropic amblyopia, with at least 12 months of follow-up. The cure criterion was a best corrected visual acuity (BCVA) of 0.1 LogMAR or better in the amblyopic eye, with less than one line of interocular difference. The potential predictors included 15 baseline clinical characteristics. Participants were randomly assigned (7:3) to the training and validation sets. A nomogram to predict the prognosis of amblyopia was computed using a logistic regression model with least absolute shrinkage and a selection operator. Model performance was assessed by discrimination (area under the curve [AUC]) and calibration (calibration plots). Results: This study included 2,897 patients, of whom 35.2% met the criteria for cured amblyopia. The training and validation sets comprised 2,040 and 857 participants, respectively. The predictors included in the nomogram were baseline age (AUC: 0.703 [95% CI 0.679-0.727]), difference in interocular BCVA (AUC: 0.688 [95% CI 0.664-0.711]), and spherical equivalence (SE) (AUC: 0.653 [95% CI 0.629-0.678]). The calibration curves of the nomogram showed good agreement between the predicted and observed probabilities, with an AUC of 0.783 (95% CI 0.763-0.803) in the training set and 0.782 (95% CI 0.750-0.814) in the validation set. Conclusion: The nomogram, incorporating baseline age, differences in interocular BCVA, and SE, provides individualized prognostic predictions for anisometropic amblyopia treatment, aiding clinicians in personalized treatment planning and better resource allocation. Furthermore, the nomogram could enhance shared decision-making with parents by providing objective prognostic data, thus improving treatment compliance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.